Project VERANDA — a survey about barriers and privacy concerns to seeking help
Official title: Project VERANDA: Requirement Analysis Survey
Run by Berlin Institute of Health @ Charité · NCT07424872 · Data updated 2026-11-12
An anonymous questionnaire for adults to see what barriers, privacy worries, and attitudes make people with sexual interest in children more or less likely to seek treatment.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Berlin Institute of Health @ Charité Academic / other |
| Locations | 1 site (Berlin, State of Berlin) |
| Status | Recruiting |
| Started | May 13, 2025 |
| Main results expected | May 14, 2026 |
| Study ends | May 14, 2026 |
| Registry record updated | March 13, 2026 |
| Trial ID | NCT07424872 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults aged 18 or older who can read English or German, including people with sexual interest in children, professionals who work with related issues, or members of the general public belonging to the defined target groups.
✕Probably not a fit
People under 18, individuals seeking direct therapeutic treatment rather than a survey, or anyone unwilling to answer sensitive questions or accept anonymized data handling are unlikely to receive benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Project VERANDA is an observational, anonymous questionnaire run in English and German that asks adults about barriers to treatment, privacy concerns, and attitudes related to sexual interest in children. Participants provide informed consent via checkbox and responses are collected without personally linkable identifiers; data are encrypted and stored on Charité servers in compliance with GDPR. The questionnaire was pilot-tested with researchers and lay volunteers to check comprehensibility, sensitivity, and technical functionality. Findings will be used to inform measures that could make treatment access and communication safer and more acceptable for affected people.
Why it matters
Potential benefit: If successful, the results could help design more private and accessible ways for people with sexual interest in children to seek help, potentially increasing treatment uptake and reducing harmful behaviors.
How similar studies have gone: Prior research shows therapy engagement can reduce offending-related behaviors and CSAM use, but comparable large-scale surveys of treatment barriers and privacy concerns are relatively uncommon, so this project builds on existing evidence.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Belonging to one of the target groups. * Otherwise, for general members of the public, none. Exclusion Criteria: * Younger than 18
Where it's running
-
Charité - Universitätsmedizin Berlin
Berlin, State of Berlin, Germany Recruiting
Study contacts
- Study coordinator: Prof. Dr.-Ing Poikela
- Email: maija.poikela@bih-charite.de
- Phone: 30 450 528 786
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Geniculate Artery Embolization for Knee Osteoarthritis in Cancer Patients
This study tests whether blocking knee blood vessels with a standard care procedure can help reduce pain and improve function in people with knee osteoarthritis who also have cancer.
-
Bridging Cancer Care for Underserved Patients with Veris Health Platform
This study tests a remote cancer care platform to see if it helps underserved adults with cancer stay connected to their care while receiving outpatient therapy.
-
Iruplinalkib for ALK-positive advanced lung adenocarcinoma after lorlatinib
We will try iruplinalkib in adults with advanced ALK-positive lung adenocarcinoma who progressed on or couldn't tolerate lorlatinib to see how well it works and how safe it is in routine care.
-
A kidney cancer prediction model to guide treatment decisions, including for patients with tumor thrombus
This project will test whether a new prediction model can guide treatment choices to improve survival for adults with renal cell carcinoma, including those with venous tumor thrombus.
-
Understanding the progression of Sialidosis Type I
This study is trying to understand how Sialidosis Type I affects people by checking their brain and eye health regularly to see how the condition changes over time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.